Nutra Pharma Corp.
    SEC Filings

    |
    |

    All SEC filings by Nutra Pharma Corp. (NPHC) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.

    Financials

    10-QQuarterly reportView DiffAug 19, 2026
    NT 10-QNotice of late quarterly filingAug 14, 2026
    10-QQuarterly reportView DiffMay 29, 2026
    10-KAnnual reportView DiffMay 20, 2026
    10-QQuarterly reportView DiffApr 6, 2026
    10-QQuarterly reportView DiffMar 25, 2026
    10-QQuarterly reportView DiffMar 11, 2026
    10-KAnnual reportView DiffFeb 17, 2026
    10-QQuarterly reportView DiffJan 2, 2026
    10-QQuarterly reportView DiffDec 23, 2025

    Events

    8-KCurrent reportSep 2, 2026
    8-KChanges in Registrant'S Certifying AccountantSep 3, 2025
    8-KDeparture of Directors or Certain OfficersMar 22, 2024
    8-KChanges in Registrant'S Certifying AccountantAug 4, 2022
    8-KChanges in Registrant'S Certifying AccountantOct 9, 2018
    8-KRegulation Fd DisclosureSep 28, 2018
    8-KDeparture of Directors or Certain OfficersMar 7, 2018
    8-KUnregistered Sales of Equity SecuritiesNov 3, 2017
    8-KChanges in Registrant'S Certifying AccountantMay 4, 2017
    8-KDeparture of Directors or Certain OfficersJul 27, 2016

    Registrations and Prospectuses

    S-1/AIPO registrationView DiffJan 6, 2011
    S-1IPO registrationDec 14, 2010
    S-8Registration of securities for employeesJun 25, 2007
    S-8Registration of securities for employeesDec 9, 2003
    SB-2/ARegistration of securities for small business issuerApr 6, 2001
    SB-2/ARegistration of securities for small business issuerMar 28, 2001
    SB-2/ARegistration of securities for small business issuerMar 14, 2001
    SB-2/ARegistration of securities for small business issuerMar 1, 2001
    8-A12GRegistration of securitiesDec 19, 2000
    SB-2/ARegistration of securities for small business issuerNov 13, 2000

    Proxies

    DEF 14CInformation statementMar 23, 2022
    PRE 14CPreliminary informationJan 14, 2022
    DEF 14CInformation statementMar 20, 2018
    PRE 14CPreliminary informationMar 8, 2018
    DEF 14ADefinitive proxyMar 17, 2015
    PRE 14APreliminary proxyMar 3, 2015
    DEF 14ADefinitive proxyOct 17, 2001

    Other

    EFFECTNotice of effectivenessJan 7, 2011
    UPLOADLetter from SECJun 24, 2010
    CORRESPCorrespondence with SECApr 8, 2010
    UPLOADLetter from SECMar 22, 2010
    CORRESPCorrespondence with SECJan 25, 2010
    CORRESPCorrespondence with SECJan 13, 2010
    CORRESPCorrespondence with SECDec 16, 2009
    UPLOADLetter from SECDec 15, 2009
    UPLOADLetter from SECOct 7, 2008
    UPLOADLetter from SECOct 7, 2008

    Ownership

    SC 13DPure Raw Supplies, Llc Acquires Stake in Nutra Pharma CorpSep 1, 2026
    3Pure Raw Supplies, LlcSep 1, 2026
    4Deitsch Rik JSep 1, 2026
    5Rik J DeitschJan 14, 2022
    SC 13D/ANutra Pharma CorpJan 14, 2022
    SC 13DNutra Pharma CorpJun 29, 2018
    4Rik J DeitschJun 26, 2018
    SC 13DNutra Pharma CorpJun 6, 2018
    SC 13G/ANutra Pharma CorpFeb 5, 2018
    SC 13GNutra Pharma CorpFeb 2, 2018